Table 1 Tumor types and number of TCGA isomiR samples used in the analysis
From: Tumor classification and biomarker discovery based on the 5’isomiR expression level
Tumor Types | # of samples |
|---|---|
Adrenocortical carcinoma [ACC] | 79 |
Bladder Urothelial Carcinoma [BLCA] | 366 |
Breast invasive carcinoma [BRCA] | 1064 |
Cervical squamous cell carcinoma and endocervical adenocarcinoma [CESC] | 299 |
Cholangiocarcinoma [CHOL] | 35 |
Colon adenocarcinoma [COAD] | 386 |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma [DLBC] | 46 |
Esophageal carcinoma [ESCA] | 183 |
Head and Neck squamous cell carcinoma [HNSC] | 487 |
Kidney Chromophobe [KICH] | 60 |
Kidney renal clear cell carcinoma [KIRC] | 455 |
Kidney renal papillary cell carcinoma [KIRP] | 261 |
Acute Myeloid Leukemia [LAML] | 105 |
Brain Lower Grade Glioma [LGG] | 497 |
Liver hepatocellular carcinoma [LIHC] | 356 |
Lung adenocarcinoma [LUAD] | 445 |
Lung squamous cell carcinoma [LUSC] | 419 |
Mesothelioma [MESO] | 82 |
Ovarian serous cystadenocarcinoma [OV] | 349 |
Pancreatic adenocarcinoma [PAAD] | 152 |
Pheochromocytoma and Paraganglioma [PCPG] | 178 |
Prostate adenocarcinoma [PRAD] | 472 |
Rectum adenocarcinoma [READ] | 144 |
Sarcoma [SARC] | 243 |
Skin Cutaneous Melanoma [SKCM] | 94 |
Stomach adenocarcinoma [STAD] | 425 |
Testicular Germ Cell Tumors [TGCT] | 149 |
Thyroid carcinoma [THCA] | 483 |
Thymoma [THYM] | 122 |
Uterine Corpus Endometrial Carcinoma [UCEC] | 514 |
Uterine Carcinosarcoma [UCS] | 55 |
Uveal Melanoma [UVM] | 80 |